MedPath

Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa

Not Applicable
Completed
Conditions
HIV Prevention
Registration Number
NCT01554423
Lead Sponsor
The City College of New York
Brief Summary

This study is a Randomized Controlled Trial (RCT) of Integrated and Cognitive Behavioral Therapy for HIV Prevention in Pretoria, South Africa. The RCT will evaluate the efficacy of a brief motivational interview (BMI) and a cognitive-behavioral couples' (IFCBT) intervention alone and in combination against a comparison condition to reduce new cases of HIV and sexually transmitted infections and increase condom use and decrease sexual risk behavior, drug use, and intimate partner violence among young female drug users in Pretoria, South Africa and their primary intimate partners. In the RCT, 384 couples comprised of young female drug users who do (N = 192) and do not (N = 192) trade sex and their primary intimate heterosexual partners will be randomly assigned to one-of-four conditions: (1) testing and counseling; (2) brief motivational interview (BMI); (3) cognitive-behavioral couples' intervention (IFCBT); or (4) BMI and IFCBT combined. Eligibility criteria for couples include an HIV-negative drug using female aged 18 to 40 and their primary intimate partner or spouse who is also HIV negative. Each partner of each couple will be administered assessments with a rapid test for HIV and urine tests for Chlamydia, gonorrhea, trichomoniasis, and drug use at baseline and 3-month, 6-month, and 12-month follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
464
Inclusion Criteria
  • Live in the Pretoria, South Africa region
  • 18-40 Years of Age
  • In a steady, intimate relationship for 6 months or longer
  • Used illicit drugs in the past 6 months
Exclusion Criteria
  • Acute suicidality/homicidality

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Drug taking risk behaviorOutcome measure will be assessed up to 18 months after enrollment.

Hazardous alcohol use, and positive urinalysis for marijuana, cocaine, heroin.

Biologically confirmed infectious disease statusOutcome measure will be assessed up to 18 months after enrollment.

Biologically confirmed infectious disease (HIV, Chlamydia, gonorrhea, and trichomoniasis)

Intimate partner violenceOutcome measure will be assessed up to 18 months after enrollment.

Psychological, physical, and sexual violence.

Condom use and sexual risk behaviorOutcome measure will be assessed up to 18 months after enrollment.

Condom use during last sexual intercourse, proportion of unprotected sex episodes; number of partners.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Louis Pasteur Medical Centre

🇿🇦

Pretoria, Gauteng, South Africa

Louis Pasteur Medical Centre
🇿🇦Pretoria, Gauteng, South Africa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.